Mid-South Anesthesia Consultants, PLLC
Mid-South Anesthesia Consultants, PLLC was paid $676K by Medicaid between Jan 2018 and Feb 2024, across 23 billing codes. Its largest line is 01967, Neuraxial labor analgesia/anesthesia for planned vaginal delivery — 39% of everything it billed.
33Billing provider infoMID-SOUTH ANESTHESIA CONSULTANTS, PLLC
SOUTHAVEN, MS 38671
SOUTHAVEN, MS 38671
33aNPI1003869520assigned 05/18/2006
33bProvider typeSpecialist
28Total paid$676K
24GClaims32,849
24DCodes billed23
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Specialist providers in Mississippi
Rank by total paid#16 of 103
Median peer was paid$86K
This provider vs. median7.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,771 | $153K | |
| 2019 | 9,531 | $130K | |
| 2020 | 3,098 | $84K | |
| 2021 | 3,130 | $114K | |
| 2022 | 3,329 | $76K | |
| 2023 | 4,686 | $112K | |
| 2024incomplete | 304 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 39% | 1,006 | 849 | $263K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 27% | 1,411 | 1,283 | $184K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 7,113 | 6,387 | $130K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.1% | 1,265 | 1,205 | $28K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 2.3% | 539 | 443 | $16K |
| 80305 | 2.1% | 5,878 | 5,185 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 1,451 | 1,332 | $12K |
| 00126 | 1.5% | 133 | 122 | $10K | |
| 01961 | <1% | 26 | 25 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 217 | 205 | $4K |
| 99406 | <1% | 2,068 | 1,854 | $4K | |
| 96146 | <1% | 156 | 136 | $2K |
11 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 31 | $2K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 12 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 489 | $152.61 |
| 96103 | <1% | 174 | $5.08 | |
| G9561 | Patients prescribed opiates for longer than six weeks | 0% | 2,064 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 1,818 | $0.00 |
| G9562 | Patients who had a follow-up evaluation conducted at least every three months during opioid therapy | 0% | 2,017 | $0.00 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 0% | 2,055 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,145 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 716 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARLETON, TERRIE (ACCOUNT MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Biloxi Anesthesiology, PLLC | Biloxi, MS | $132K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.